Omicron wave during December 2022 - January 2023: access to pharmaceuticals and healthcare resources and impacts on health outcomes in Shenzhen, China.
Jiayue ChenHaisu FengJiatong SunYawen Jiang
Published in: Journal of pharmaceutical policy and practice (2024)
Shenzhen residents with COVID-19 symptoms from December 2022 to January 2023 experienced a certain degree of pharmaceutical and medical resource constraints, which might have compromised their prognosis.